AD

tert-butyl ((2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl)carbamate(CAS: 1172623-98-1)

tert-butyl ((2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl)carbamate
CAS Number

Related Products

Other Suppliers for tert-butyl ((2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl)carbamate

Basic Information

Molecular Formula
C16H19F2NO3
Molecular Weight
311.33 g/mol

Physical Properties

Boiling Point
395.8±42.0°C at 760 mmHg

Chemical Identifiers

SMILES
CC(C)(C)OC(=O)NC1CC=COC1C2=C(C=CC(=C2)F)F
InChIKey
OLXPRJZWYJVTID-UONOGXRCSA-N

Database References

MDL Number
MFCD28144045

FAQ

This compound must comply with GHS classification for hazardous chemicals, REACH regulations in the EU for registration, evaluation, authorization, and restriction of chemicals, and FDA/EPA requirements for safety and environmental impact assessments. It is also subject to local and international regulations regarding storage, transport, and disposal.
Common alternatives include using other cyclic esters such as tetrahydrofuran or other carbamates with different substituents. Isomers and analogs like (2S,3R)-isomers or related pyran derivatives may also be considered as substitutes depending on the specific reaction conditions and desired product properties.
Research trends for this compound indicate increased interest in its use as a chiral building block for pharmaceuticals and agrochemicals. Market trends suggest growing demand, driven by advancements in synthetic methodologies and the expansion of applications in drug discovery and development.
Waste containing this compound should be collected and disposed of in accordance with local and international regulations. Proper incineration or professional waste disposal services are recommended to ensure environmental safety. Additional precautions include neutralizing the waste before disposal and following strict environmental protection guidelines.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Contact Person

Li Li

Email

sales@qingypharma.com